Stromedix Report issue

For profit Phase 2
Founded: Cambridge MA United States (2007)
Status: Acquired by Biogen-IDEC (2012)

Organization Overview

First Clinical Trial
2010
NCT00878761
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Stromedix, Inc.